Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-28

Clinical Trial Update: Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Remodeling [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effects of dapagliflozin on functional mitral regurgitation and myocardial remodeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Functional Mitral Regurgitation | Phase 4 | Status: UNKNOWN